Aandelen in “Biotechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
13/02 | 1,890 USD
+3,28% |
+3,28% |
|
Cabaletta Bio Inc |
13/02 | 2,800 USD
-1,75% |
-1,75% |
|
Calithera Biosciences Inc |
13/02 | 0,000 USD
0,00% |
0,00% |
|
Can-Fite Biopharma Ltd |
13/02 | 4,530 USD
+4,86% |
+4,86% |
|
Capricor Therapeutics Inc |
13/02 | 22,450 USD
-5,15% |
-5,15% |
Carbios |
13/02 | 10,050 EUR
+1,01% |
+1,01% |
|
Carisma Therapeutics, Inc. |
13/02 | 0,045 USD
+12,11% |
+12,11% |
|
CASI Pharmaceuticals Inc |
13/02 | 0,850 USD
+13,33% |
+13,33% |
|
Cel-Sci Corp. |
13/02 | 4,900 USD
+6,52% |
+6,52% |
|
Celldex Therapeutics Inc. |
13/02 | 23,000 USD
-2,42% |
-2,42% |
|
Cellectar Biosciences Inc |
13/02 | 3,290 USD
+4,78% |
+4,78% |
|
Cellectis |
13/02 | 3,730 USD
+6,88% |
+6,88% |
|
Cellectis |
13/02 | 3,305 EUR
+6,61% |
+6,61% |
Celyad Oncology |
13/02 | 0,328 EUR
+20,59% |
+20,59% |
|
Champions Oncology Inc |
13/02 | 6,080 USD
+2,18% |
+2,18% |
|
Cidara Therapeutics Inc |
6/01 | 221,380 USD
+0,03% |
+0,03% |
|
Co-Diagnostics Inc |
13/02 | 2,490 USD
+5,96% |
+5,96% |
|
Cogent Biosciences Inc |
13/02 | 36,530 USD
-0,52% |
-0,52% |
|
Coherus Biosciences Inc |
13/02 | 1,610 USD
-19,90% |
-19,90% |
|
CollPlant Biotechnologies Ltd |
13/02 | 0,720 USD
+5,88% |
+5,88% |
|
Compass Pathways Plc |
13/02 | 5,810 USD
-0,68% |
-0,68% |
|
Compugen Ltd. |
13/02 | 1,650 USD
-1,20% |
-1,20% |
|
Corbus Pharmaceuticals Holdings Inc |
13/02 | 7,560 USD
-3,45% |
-3,45% |
|
CRISPR Therapeutics AG |
13/02 | 53,070 USD
+8,46% |
+8,46% |
|
Cue Biopharma Inc |
13/02 | 0,307 USD
+2,20% |
+2,20% |
|
Curis Inc |
13/02 | 1,150 USD
+6,48% |
+6,48% |
|
Cytokinetics Inc |
13/02 | 66,260 USD
+1,88% |
+1,88% |
|
CytomX Therapeutics Inc |
13/02 | 5,320 USD
-2,03% |
-2,03% |